Psilocybin for psychiatric disorders: History, clinical trials, neuroimaging, and regulations
Psychiatry and Clinical Neurosciences February 26, 2026 Kengo Yonezawa, Mika Hirata, Hiroaki Takano et al. 1 citation
Psilocybin, a classic psychedelic compound, has garnered renewed interest as a potential treatment for various psychiatric disorders. This review provides a comprehensive overview of psilocybin's history, recent clinical evidence, ongoing clinical trials, neuroimaging findings, and regulations. Historically used in spiritual and healing rituals, psilocybin was in the early 1970s subjected to...
DOI: 10.1111/pcn.70042 (opens in new tab)
Psilocybin
Major depressive disorder
Clinical trial
Hallucinogen
+4